Co-diagnostics vs Itonic Holdings
Co-diagnostics is the larger business, with $622,489 of revenue in fiscal 2025 against $523,031 for Itonic Holdings (1.2 times as much). Itonic Holdings grew faster (16.7% against -84.1%). Itonic Holdings kept more of each dollar of sales as profit: a net margin of -974.7% against -7533.6%. Co-diagnostics carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Co-diagnosticsCODX, 2025 | Itonic HoldingsITOC, 2025 |
|---|---|---|
| Revenue | $622,489 | $523,031 |
| Revenue growth | -84.1% | 16.7% |
| Net income | −$46.9m | −$5.1m |
| Operating margin | -8058.8% | -991.7% |
| Net margin | -7533.6% | -974.7% |
| Return on equity | -125.9% | -82.8% |
| Free cash flow | −$29.8m | −$3.2m |
| Cash | $11.9m | $1.5m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 115 | — |
| Market value | $1.7m | $37.7m |
| Price vs our value range | — | — |
| Moat score | 24 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |